Clarify the Role of Winlevi for Acne

February 2021

Rx Winlevi (clascoterone) 1% cream will be the first topical androgen receptor inhibitor for treating acne.

Think of Winlevi's role as similar to spironolactone or OCs for females. It's a "hormonal" option that can be used regardless of gender.

But tell patients not to get too excited.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Guide Use of mRNA COVID-19 Vaccines for Special Populations
COVID-19 Know the Ins and Outs of Giving mRNA COVID-19 Vaccines
COVID-19 Clear Up Confusion About Outpatient Treatments for COVID-19
COVID-19 Point Out Pros and Cons of the Ellume COVID-19 Home Test
Heart Failure Don't Jump to Spironolactone or Entresto for HFpEF
STIs Expect a Shift to Just One Antibiotic for Treating Gonorrhea
Hormone Therapy Be Familiar With Hormone Therapies for Transgender Patients
Gastroenterology Evaluate Appropriate Use of Pancreatic Enzymes
Acne Clarify the Role of Winlevi for Acne